| Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery N Hüser, CW Michalski, M Erkan, T Schuster, R Rosenberg, J Kleeff, ... Annals of surgery 248 (1), 52-60, 2008 | 722 | 2008 |
| The role of stroma in pancreatic cancer: diagnostic and therapeutic implications M Erkan, S Hausmann, CW Michalski, AA Fingerle, M Dobritz, J Kleeff, ... Nature reviews Gastroenterology & hepatology 9 (8), 454-467, 2012 | 664 | 2012 |
| The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma M Erkan, CW Michalski, S Rieder, C Reiser–Erkan, I Abiatari, A Kolb, ... Clinical gastroenterology and hepatology 6 (10), 1155-1161, 2008 | 499 | 2008 |
| StellaTUM: current consensus and discussion on pancreatic stellate cell research M Erkan, G Adler, MV Apte, MG Bachem, M Buchholz, S Detlefsen, ... Gut 61 (2), 172-178, 2012 | 470 | 2012 |
| Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity M Erkan, J Kleeff, A Gorbachevski, C Reiser, T Mitkus, I Esposito, T Giese, ... Gastroenterology 132 (4), 1447-1464, 2007 | 381 | 2007 |
| Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma PK Mazur, A Herner, SS Mello, M Wirth, S Hausmann, FJ Sánchez-Rivera, ... Nature medicine 21 (10), 1163-1171, 2015 | 370 | 2015 |
| Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma M Erkan, C Reiser-Erkan, CW Michalski, S Deucker, D Sauliunaite, ... Neoplasia 11 (5), 497-508, 2009 | 365 | 2009 |
| Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase DA Ruess, GJ Heynen, KJ Ciecielski, J Ai, A Berninger, D Kabacaoglu, ... Nature medicine 24 (7), 954-960, 2018 | 341 | 2018 |
| Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis M Erkan, J Kleeff, I Esposito, T Giese, K Ketterer, MW Büchler, NA Giese, ... Oncogene 24 (27), 4421-4432, 2005 | 260 | 2005 |
| Inter‐and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma C Neuzillet, A Tijeras‐Raballand, C Ragulan, J Cros, Y Patil, M Martinet, ... The Journal of pathology 248 (1), 51-65, 2019 | 256 | 2019 |
| Intracellular autofluorescence: a biomarker for epithelial cancer stem cells I Miranda-Lorenzo, J Dorado, E Lonardo, S Alcala, AG Serrano, ... Nature methods 11 (11), 1161-1169, 2014 | 220 | 2014 |
| Northern blot analysis for detection and quantification of RNA in pancreatic cancer cells and tissues S Streit, CW Michalski, M Erkan, J Kleeff, H Friess Nature protocols 4 (1), 37-43, 2009 | 206 | 2009 |
| Inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms M Cioffi, S Trabulo, M Hidalgo, E Costello, W Greenhalf, M Erkan, J Kleeff, ... Clinical cancer research 21 (10), 2325-2337, 2015 | 197 | 2015 |
| The neurotrophic factor artemin promotes pancreatic cancer invasion GO Ceyhan, NA Giese, M Erkan, AG Kerscher, MN Wente, T Giese, ... Annals of surgery 244 (2), 274-281, 2006 | 186 | 2006 |
| Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling A Balic, MD Sørensen, SM Trabulo, B Sainz Jr, M Cioffi, CR Vieira, ... Molecular cancer therapeutics 13 (7), 1758-1771, 2014 | 163 | 2014 |
| Impaired autophagy induces chronic atrophic pancreatitis in mice via sex-and nutrition-dependent processes KN Diakopoulos, M Lesina, S Wörmann, L Song, M Aichler, L Schild, ... Gastroenterology 148 (3), 626-638. e17, 2015 | 159 | 2015 |
| Cannabinoids in pancreatic cancer: correlation with survival and pain CW Michalski, FE Oti, M Erkan, D Sauliunaite, F Bergmann, P Pacher, ... International journal of cancer 122 (4), 742-750, 2008 | 159 | 2008 |
| The role of hypoxia in pancreatic cancer: a potential therapeutic target? M Erkan, M Kurtoglu, J Kleeff Expert review of gastroenterology & hepatology 10 (3), 301-316, 2016 | 150 | 2016 |
| Tumor microenvironment and progression of pancreatic cancer M Erkan, C Reiser-Erkan, CW Michalski, J Kleeff Exp Oncol 32 (3), 128-131, 2010 | 147 | 2010 |
| Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment B Sainz, S Alcala, E Garcia, Y Sanchez-Ripoll, MM Azevedo, M Cioffi, ... Gut 64 (12), 1921-1935, 2015 | 141 | 2015 |
